
Keywords: CDK; cyclin-dependent kinase; PTMs; post-translational modifications; AR; androgen receptor; PCa; prostate cancer; PSA; prostate specific antigen; ENZ; enzalutamide; CSS; charcoal stripped serum; FBS; fetal bovine serum; ER; estrogen receptor; PR; progest